Glycorex Transplantation
PUBLIC
STATUS
21-30
EMPLOYEES
GTAB B
STOCK SYMBOL
$1.40
SHARE PRICE
(As of Friday Closing)
Description
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Stock Exchange
NGM
Primary Office
- Solvegatan 41
- 223 70 Lund
- Sweden
+46 046-286 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Glycorex Transplantation’s full profile, request a free trial.
Glycorex Transplantation Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.25 - $1.66 | $101M | $1.45 | $0.01 | 207K | 69.9M |
Glycorex Transplantation Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 49,366 | 14,753 | 17,676 | 21,312 |
| Revenue | 4,087 | 3,838 | 3,459 | 3,906 |
| EBITDA | 1,257 | 458 | 104 | 430 |
| Net Income | 792 | 329 | (1,855) | 138 |
| Total Assets | 8,455 | 7,444 | 6,687 | 7,804 |
| Total Debt | 1,269 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer